Assignee
PREVAIL THERAPEUTICS INC
US·14 granted patents·13 pending applications·41 citations·filing 2018–2024
Top patents by PatentIndex Score
27 records- 0195US11661585B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 30, 2023·5 cites·19 claims
- 0295US11060113B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·8 cites·15 claims
- 0395US10689625B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·10 cites·17 claims
- 0493US11655460B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·3 cites·14 claims
- 0593US10837028B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Nov 17, 2020·9 cites·17 claims
- 0686US11802294B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Oct 31, 2023·2 cites·44 claims
- 0785US12570963B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2023·Granted Mar 10, 2026·0 cites·15 claims
- 0884US11993790B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted May 28, 2024·1 cites·20 claims
- 0981US11903985B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Feb 20, 2024·1 cites·24 claims
- 1081US11807849B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Nov 7, 2023·1 cites·41 claims
- 1181US2025011783A1Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1277US12516298B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2024·Granted Jan 6, 2026·0 cites·9 claims
- 1376US12571002B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2021·Granted Mar 10, 2026·0 cites·23 claims
- 1475US11999974B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jun 4, 2024·1 cites·13 claims
- 1572US2024123003A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1669US12049626B2Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 30, 2024·0 cites·18 claims
- 1758US2023304036A1Aav vectors encoding parkin and uses thereofPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1857US2023405149A1Gene therapies for neurodegenerative diseasePREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1957US2024100132A1Modulation of aav-based gene expressionPREVAIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2054US2022119843A1Recombinant adeno-associated virus compositions and methods for producing samePREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2153US2022211871A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2253US2020283800A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2351US2023346979A1Gene therapies for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2451US2023310654A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2551US2022010001A1Gene therapies for neurodegenerative diseasePREVAIL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2647US2024044869A1Assay for measuring potency of gene therapy drug productPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2746US2021261981A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PREVAIL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →